Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Public ClinicalTrials.gov record NCT05225415. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Study identification
- NCT ID
- NCT05225415
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Cognition Therapeutics
- Industry
- Enrollment
- 130 participants
Conditions and interventions
Conditions
Interventions
- CT1812 Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2022
- Primary completion
- Nov 24, 2024
- Completion
- Nov 24, 2024
- Last update posted
- Mar 11, 2026
2022 – 2024
United States locations
- U.S. sites
- 34
- U.S. states
- 19
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | 85013 | — |
| Banner Sun Health Research Institute | Sun City | Arizona | 85351 | — |
| University of Arizona - Health Sciences Center | Tucson | Arizona | 85724 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| Pacific Neuroscience Institute | Santa Monica | California | 90404 | — |
| University of Colorado | Aurora | Colorado | 80045 | — |
| CenExel Rocky Mountain Clinical Research, LLC | Englewood | Colorado | 80113 | — |
| New England Institute for Neurology and Headache (NEINH) | Stamford | Connecticut | 06905 | — |
| JEM Research Institute | Atlantis | Florida | 33462 | — |
| University of Miami Miller School of Medicine Comprehensive Center for Brain Health | Boca Raton | Florida | 33433 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| Charter Research | Lady Lake | Florida | 32156 | — |
| Renstar Medical Research | Ocala | Florida | 34770 | — |
| Charter Research | Winter Park | Florida | 32792 | — |
| Rush University Medical Center Section of Parkinson Disease and Movement Disorder | Chicago | Illinois | 60612 | — |
| IU Health Neuroscience Center, Goodman Hall | Indianapolis | Indiana | 46202 | — |
| Josephson Wallack Munshower Neurology, P.C | Indianapolis | Indiana | 46256 | — |
| The University of Kansas Alzheimer's Disease Research Center | Fairway | Kansas | 66205 | — |
| University of Kentucky | Lexington | Kentucky | 40504 | — |
| Headlands Research Eastern Massachusetts, LLC | Plymouth | Massachusetts | 02360 | — |
| Mayo Clinic | Rochester | Minnesota | 55905 | — |
| Columbia University | New York | New York | 10032 | — |
| UNC Department of Neurology | Chapel Hill | North Carolina | 27599 | — |
| Cleveland Clinic Main Campus | Cleveland | Ohio | 44195 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Summit Headlands, LLC | Portland | Oregon | 97210 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19107 | — |
| University of Texas Southwestern | Dallas | Texas | 75390 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
| University of Virginia Adult Neurology | Charlottesville | Virginia | 22903 | — |
| Virginia Commonwealth University | Richmond | Virginia | 23298 | — |
| Evergreen Health Research | Kirkland | Washington | 98034 | — |
| Universtiy of Washington Department of Neurology | Seattle | Washington | 98104 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05225415, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 11, 2026 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05225415 live on ClinicalTrials.gov.